Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.

Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Møller K, Iversen M, Banke MB, Petersen IJ, Klingenberg SL, Krogh J, Ebert SE, Timm A, Lindschou J, Gluud C.

BMC Psychiatry. 2017 Feb 8;17(1):58. doi: 10.1186/s12888-016-1173-2.

2.

St. John's Wort for Major Depressive Disorder: A Systematic Review.

Maher AR, Hempel S, Apaydin E, Shanman RM, Booth M, Miles JN, Sorbero ME.

Rand Health Q. 2016 May 9;5(4):12. eCollection 2016 May 9.

3.

A systematic review of St. John's wort for major depressive disorder.

Apaydin EA, Maher AR, Shanman R, Booth MS, Miles JN, Sorbero ME, Hempel S.

Syst Rev. 2016 Sep 2;5(1):148. doi: 10.1186/s13643-016-0325-2.

4.
5.

Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode - a subgroup analysis.

Seifritz E, Hatzinger M, Holsboer-Trachsler E.

Int J Psychiatry Clin Pract. 2016 Sep;20(3):126-32. doi: 10.1080/13651501.2016.1179765. Epub 2016 May 10.

6.

Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.

Jakubovski E, Varigonda AL, Freemantle N, Taylor MJ, Bloch MH.

Am J Psychiatry. 2016 Feb 1;173(2):174-83. doi: 10.1176/appi.ajp.2015.15030331. Epub 2015 Nov 10. Review.

7.

Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials.

Sim K, Lau WK, Sim J, Sum MY, Baldessarini RJ.

Int J Neuropsychopharmacol. 2015 Jul 7;19(2). pii: pyv076. doi: 10.1093/ijnp/pyv076. Review.

8.
9.

Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Lee J, Jo DG, Park D, Chung HY, Mattson MP.

Pharmacol Rev. 2014 Jul;66(3):815-68. doi: 10.1124/pr.113.007757. Review.

10.

Mood disorders and complementary and alternative medicine: a literature review.

Qureshi NA, Al-Bedah AM.

Neuropsychiatr Dis Treat. 2013;9:639-58. doi: 10.2147/NDT.S43419. Epub 2013 May 14.

11.

A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease.

Wang X, Xu X, Tao W, Li Y, Wang Y, Yang L.

Evid Based Complement Alternat Med. 2012;2012:519031. doi: 10.1155/2012/519031. Epub 2012 Nov 29.

12.

Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review.

Undurraga J, Baldessarini RJ.

Neuropsychopharmacology. 2012 Mar;37(4):851-64. doi: 10.1038/npp.2011.306. Epub 2011 Dec 14. Review.

13.

Review of pharmacological treatment in mood disorders and future directions for drug development.

Li X, Frye MA, Shelton RC.

Neuropsychopharmacology. 2012 Jan;37(1):77-101. doi: 10.1038/npp.2011.198. Epub 2011 Sep 7. Review.

14.

A longitudinal etiologic model for symptoms of anxiety and depression in women.

Kendler KS, Gardner CO.

Psychol Med. 2011 Oct;41(10):2035-45. doi: 10.1017/S0033291711000225. Epub 2011 Apr 11.

15.

Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.

Bitran S, Farabaugh AH, Ameral VE, LaRocca RA, Clain AJ, Fava M, Mischoulon D.

Int Clin Psychopharmacol. 2011 Jul;26(4):206-12. doi: 10.1097/YIC.0b013e328343ba08.

16.

Update and critique of natural remedies as antidepressant treatments.

Mischoulon D.

Obstet Gynecol Clin North Am. 2009 Dec;36(4):789-807, x. doi: 10.1016/j.ogc.2009.10.005.

17.

Nutritional therapies for mental disorders.

Lakhan SE, Vieira KF.

Nutr J. 2008 Jan 21;7:2. doi: 10.1186/1475-2891-7-2. Review.

Supplemental Content

Support Center